Are you Dr. Gowhari?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1740 W Taylor St
Chicago, IL 60612Phone+1 866-600-2273Fax+1 312-996-5984
Summary
- Dr. Michel Gowhari, DO is a board certified internist in Chicago, Illinois. He is currently licensed to practice medicine in Illinois. He is affiliated with University of Illinois Hospital and is an Instructor at University of Illinois College of Medicine.
Education & Training
- University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 2006 - 2007
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2000 - 2003
- Arizona College of Osteopathic Medicine of Midwestern UniversityClass of 2000
Certifications & Licensure
- IL State License 2003 - 2026
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Phase II Trial of Regadenoson in Sickle Cell Anemia Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease.Jin Han, Santosh L. Saraf, Michel Gowhari, Faiz Ahmed Hussain, Shivi Jain
The Annals of Pharmacotherapy. 2021-06-19 - Evaluation of point-of-care International Normalized Ratio in sickle cell disease.Syeda Rahman, Andrew Srisuwananukorn, Robert E. Molokie, Michel Gowhari, Franklin Njoku
Research and Practice in Thrombosis and Haemostasis. 2021-05-01 - 2 citationsAntimicrobial resistance is a risk factor for mortality in adults with sickle cell disease.Andrew Srisuwananukorn, Jin Han, Rasha Raslan, Michel Gowhari, Faiz Ahmed Hussain
Haematologica. 2020-10-29